{
  "resourceType": "PlanDefinition",
  "id": "ANCDT09",
  "url": "http://fhir.org/guides/who/anc-cds/PlanDefinition/ANCDT09",
  "identifier": [ {
    "use": "official",
    "value": "ANC.DT.09"
  } ],
  "name": "ANCDT09",
  "title": "ANC.DT.09 Heptatitis B testing",
  "type": {
    "coding": [ {
      "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type",
      "code": "eca-rule"
    } ]
  },
  "status": "active",
  "experimental": false,
  "date": "2021-04-19T22:35:05-06:00",
  "description": "Depending on the population prevalence, and woman's medical history, conduct hepatitis B testing",
  "useContext": [ {
    "code": {
      "system": "http://terminology.hl7.org/CodeSystem/usage-context-type",
      "code": "task",
      "display": "Workflow Task"
    },
    "valueCodeableConcept": {
      "coding": [ {
        "system": "http://fhir.org/guides/who/anc-cds/CodeSystem/activity-codes",
        "code": "ANC.B9.",
        "display": "Conduct laboratory tests and imaging"
      } ]
    }
  } ],
  "library": [ "http://fhir.org/guides/who/anc-cds/Library/ANCDT09" ],
  "action": [ {
    "title": "ANC.DT.09 Heptatitis B testing",
    "trigger": [ {
      "type": "named-event",
      "name": "ANC.B9. Conduct laboratory tests and imaging"
    } ],
    "action": [ {
      "id": "1",
      "description": "\"Hepatitis B test required\" = TRUE",
      "documentation": [ {
        "type": "citation",
        "label": "Guidelines on hepatitis B and C testing (2017): Recommendation 2 (4)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "\"Population prevalence of hepatitis B\" â‰¥ 2%",
          "language": "text/cql-identifier",
          "expression": "Should \\\"Hepatitis B test required\\\" = TRUE"
        }
      } ],
      "action": [ {
        "title": "Conduct hepatitis B test"
      }, {
        "title": "Hepatitis B testing is recommended for at-risk women.\nHBsAg laboratory-based immunoassay is the preferred method for testing for Hep B infection in pregnancy; if immunoassay is not available, HBsAg rapid diagnostic test (RDT) is recommended over dried blood spot (DBS) HBsAg testing."
      } ]
    }, {
      "id": "2",
      "title": "Conduct hepatitis B test",
      "description": "\"Hepatitis B test required\" = TRUE",
      "documentation": [ {
        "type": "citation",
        "label": "Guidelines on hepatitis B and C testing (2017): Recommendation (4)"
      } ],
      "condition": [ {
        "kind": "applicability",
        "expression": {
          "description": "((\"HIV status\" = \"HIV positive\")\n  OR (Current alcohol and/or other substance use\" = \"Injectable drugs\"))\n  OR (\"Occupation\" = \"Employment that puts woman at increased risk for HIV (e.g. sex worker)\")",
          "language": "text/cql-identifier",
          "expression": "Should \\\"Hepatitis B test required\\\" = TRUE"
        }
      } ]
    } ]
  } ]
}